
    
      The primary objective of the study is:

      â€¢ To characterise the pharmacokinetic (PK) profile of teverelix following single dose,
      subcutaneous (s.c.) and intramuscular (i.m.) administration of teverelix TFA in healthy male
      subjects

      The secondary objectives of the study are:

        -  To assess the safety and tolerability of teverelix TFA after single s.c. and i.m.
           injections in healthy male subjects

        -  To evaluate pharmacodynamics (PD) effects of teverelix following single dose, s.c. and
           i.m. administration of teverelix TFA in healthy male subjects
    
  